Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

L-Pyr-L-Glu-L-Gln-L-Leu-L-Glu-L-Arg-L-Ala-L-Leu-L-Asn-L-Ser-L-Ser

EU orphan designation number: EU/3/13/1191   
Active ingredient: L-Pyr-L-Glu-L-Gln-L-Leu-L-Glu-L-Arg-L-Ala-L-Leu-L-Asn-L-Ser-L-Ser
Indication: Treatment of sarcoidosis
Sponsor: Araim Pharma Europe Ltd
The Coach House, The Square, Sawbridgeworth, Herts, CM21 9AE, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
09/10/2013 Centralised Orphan - Designation EMA/OD/081/13 (2013)6736 of 07/10/2013